Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia

Title
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia
Authors
Keywords
Combination therapy, FLT-3 inhibitors, Hypomethylating agents, Targeted agents
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume 15, Issue -, Pages S73-S79
Publisher
Elsevier BV
Online
2015-08-19
DOI
10.1016/j.clml.2015.02.033

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started